Bökenkamp Arend, Ariceta Gema, Böckenhauer Detlef, Devuyst Olivier, Emma Francesco, van Bennekom David, Levtchenko Elena, Sayer John, Servais Aude, Vargas Rosa, Zaniew Marcin, Prikhodina Larisa
Department of Pediatric Nephrology, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Pediatric Nephrology, Hospital Vall d' Hebron, Autonomous University of Barcelona, Barcelona, Spain.
Nephrol Dial Transplant. 2025 Apr 28;40(5):852-864. doi: 10.1093/ndt/gfaf003.
Dent disease is a rare X-linked tubulopathy that is characterized by low-molecular-weight proteinuria associated with hypercalciuria, which may lead to nephrolithiasis, nephrocalcinosis, and kidney failure between the third and fifth decades of life in 30%-80% of affected males. The disease is most often associated with various manifestations of proximal tubular dysfunction. Affected individuals may present nephrotic-range proteinuria which may be misinterpreted and cause diagnostic delay. Due to its rarity, there is limited evidence to guide diagnosis and management. These clinical practice recommendations summarize the current knowledge on Dent disease and provide guidance for diagnosis and management. The recommendations are based on a systematic search of the literature and were endorsed by a Delphi procedure among stakeholders in the field as well as the respective ERA and ESPN working groups.
丹特病是一种罕见的X连锁肾小管病,其特征是低分子量蛋白尿伴高钙尿症,这可能导致30%-80%的患病男性在30至50岁之间出现肾结石、肾钙质沉着症和肾衰竭。该疾病最常与近端肾小管功能障碍的各种表现相关。受影响的个体可能出现肾病范围的蛋白尿,这可能会被误诊并导致诊断延迟。由于其罕见性,指导诊断和管理的证据有限。这些临床实践建议总结了目前关于丹特病的知识,并为诊断和管理提供指导。这些建议基于对文献的系统检索,并得到了该领域利益相关者以及各自的ERA和ESPN工作组通过德尔菲程序的认可。